Issue 137

Exploring eating disorders and psychedelics

PSYCH Symposium is returning on 6 July to the British Museum, where a panel of experts will discuss how psychedelics could innovate eating disorder care.

With the prevalence of eating disorders increasing by 140% in the last 10 years, there is a desperate need for innovative approaches to eating disorder care. PSYCH Symposium’s panel, ‘Treating Eating Disorders: Building Patterns & Reducing Prevalence’ will explore how psychedelics can create potential mechanisms for the brain to cope with the key triggers of such conditions.

We spoke to panel members Professor Rebecca Park, Associate Professor & Honorary Consultant Psychiatrist at Oxford University, and Yoel Golbert, Co-Investigator at Sheba Medical Center Department For Eating Disorders, Co-Investigator at Sheba Medical Center Department For Eating Disorders, ahead of the event to find out more.

READ MORE

AWAKN LIFE SCIENCES COMPLETES SALE OF AWAKN CLINICS LONDON

The UK-based subsidiary was purchased by Awakn Via Amitis, owned by Via (formerly WDP) and Amitis Group

Read More

INNOVATING THE DELIVERY OF PSYCHEDELIC-ASSISTED THERAPY

Doug Drysdale, CEO at Cybin, spoke with Psychedelic Health on the company’s novel molecules – CYB003 and CYB004.

Read More

BUSINESS AND INVESTMENT

Small Pharma reports 2023 fiscal results. The company had US$18.5 million cash as of 28 February 2023.

Awakn Life Sciences completes sale of Awakn Clinics London. The subsidiary was purchased by Via (formerly WDP) and Amitis Group.

Reunion Neuroscience releases 2023 financial results. The company had C$27.7 million cash as of 31 March 2023.

Cybin to participate in PSYCH Symposium: London 2023. Chief Medical Officer Amir Inamdar will discuss challenges in drug development.

Filament Health signs licensing agreement with NeoLumina Bioscience. Filament will license PEX010 to NeoLumina for research and development related to eating disorders.

A grey market emerges in Colorado after voters approved psychedelic substances. Psychedelic-assisted therapy will be legally available in the state in 2025.

SCIENCE AND RESEARCH

Government of Canada invests nearly C$3 million to study psilocybin-assisted psychotherapy. Psilocybin will be researched to treat mental health and substance use disorders.

Robert F Kennedy Jr. pledges to legalise psychedelic medicines. The 2024 presidential candidate said he would enact widespread reforms if elected to the White House.

US lawmakers applaud FDA on guidance for psychedelic research. The development had been requested through a new bill days before the agency released the direction.

California Assembly Committee approves bill to legalise psychedelic medicine. The legislation was introduced by Senator Scott Wiener.

Join us for an action-packed agenda where leading experts and scientists will come together to bring you exclusive presentations and discussions on stage. Talking points include:

  • Challenges in psychedelic drug development
  • Policing and psychedelics: solutions for police are solutions for society
  • Reassessing the psychedelic space: what are the realities of the current market?
  • The future of psychedelic medicine in the EU
  • Neuroimaging and psychedelics – the past, present, and future
  • Atlantic psychedelics: from discovery to delivery
  • Clearing a path for treatment: the importance of facilitators and therapists
  • Shifting perceptions: assessing the ways in which psychedelic medicine could help to shape society.
FULL LIST OF SPEAKERS

REGULATION AND LEGISLATION

UK government urged to ease restrictions on accessing psilocybin. The scheduling of the psychedelic medicine is hampering scientific research.

Robert F Kennedy Jr. pledges to legalise psychedelic medicines. The 2024 presidential candidate said he would enact widespread reforms if elected to the White House.

US lawmakers applaud FDA on guidance for psychedelic research. The development had been requested through a new bill days before the agency released the direction.

ARTICLES OF INTEREST

UK Health Secretary launches investigation into mental health scandals. Undercover investigations exposed abuse in mental health facilities.

Mental health in the UK armed forces. One in eight personnel sought help in military healthcare settings.

President Biden reportedly open-minded on the use of psychedelic-assisted therapy. The president’s brother revealed Biden’s sentiment in a radio interview.

Partner with us